| Particulars |
|
|
|
|
Company Name
| iSERA Lifesciences Ltd
|
Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
8.41 |
B.V. (₹) |
9.80 |
| Sales(₹ Cr.) |
1.36 |
NP (₹ Cr.) |
0.26 |
| NP Var% |
87.00 |
Div% |
0.00 |
| CPS(₹) |
0.30 |
EPS (₹) |
0.30 |
| Traded Value(₹ Lakhs) |
3.61 |
52 Week High |
124.00 |
| 52 Week Low |
2.00 |
Price BSE |
124.00 |
| Price NSE |
0.00 |
Market Capital (₹ Cr.) |
104.41 |
| P/C Ratio |
402.00 |
P/E Ratio |
402.00 |
| Price Vs.BV |
12.65 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
1.16 |
| NP(₹ Cr.) |
0.55 |
NP Var % |
141.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
0.00 |
| OPM |
0.00 |
NP |
-0.06 |
| NP Var% |
86.62 |
EPS |
0.31 |
| PE |
400.55 |
|
|